popular wires

Todays breakfast journey was served up by an Aussie farmer. FarmCap now serves up agricultural private credit on a platter for investors.

After Carl Capolingua's deep dive into the most consistent dividends payers in the ASX 100, IML's Mike O'Neill shares his top picks.

At the smaller end of the market, where companies are less closely followed and analysed, it can often take significant announcements or newsflow to get investors to...

Austal now has 12 US defence programs — but it all began with a $200K startup. Here’s how John Rothwell got it there.

Everyone hates the idea of losing money on shares, but can the fear hold you back from a lifetime of financial optimisation?

Forget dividends alone: Talaria’s unique strategy harvests income from market volatility while preserving capital via valuation discipline.

Trump’s tariff backdown hit the price but supply-demand themes remain strong; Sunstone among potential targets; ETM's Spanish acquisition.

Boss Energy's warning of production problems at its Honeymoon Mine led the market to dump shares pronto.

ASX holds steady ahead of reporting season, rate cut odds firm, global earnings mixed, and Boss Energy dives on cost blowout.

This is the Apprentice, markets edition. Jun Bei Liu, Ben Richards, Henry Jennings and more name their highest-conviction buys and sells.

A miner takes back the top spot, while Aussie tech has so far avoided big short interest despite huge selloff. Will it last?

Not sure where to start this ASX FY25 reporting season? NAOS analyses keywords in earnings call transcripts to reveal the common themes.

Plato's Peter Gardner and Atlas' Hugh Dive run the ruler over stocks with above-market yields. They also share a top pick each.

Stock price swings on earnings day have nearly doubled in 20 years as markets price information instantly, eliminating gradual adjustments.

Wilson AM’s Damien Boey explains how the WAM Income Maximiser blends equity and debt to deliver flexible, inflation-aware monthly income.

The Fed should cut rates given consumer spending has stalled and core inflation is tracking slightly below its forecast profile.

Elston’s Bruce Williams discuss ResMed's results and margin momentum, and whether the stock still deserves a buy rating.

After crashing more than 30% this week, Novo Nordisk has now seen its share price fall 65% over the last 12 months.

The Mag Seven make up nearly 35% of the S&P 500, but Ellerston’s Nick Markiewicz says the next AI winners won’t be the names everyone knows.

Reporting season is stressful, but it also serves as a reminder of the importance of stepping back to reflect on broader themes shaping the world around us. One topic...